Drug Profile
Doxazosin controlled release - Shiner Pharm
Alternative Names: HaxasinLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Shiner Pharm Corp
- Class Antihypertensives; Quinazolines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Benign prostatic hyperplasia; Hypertension
Most Recent Events
- 30 Jan 2019 Chemical structure information added